Societatea Română de Reumatologie


Proposal for a new nomenclature of disease-modifying antirheumatic drugs
Josef S Smolen, Désirée van der Heijde, Klaus P Machold et al.
Ann Rheum Dis 2014, 73:3-5, doi:10.1136/annrheumdis-2013-204317

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S Smolen, Jürgen Braun, Maxime Dougados et al.
Ann Rheum Dis 2014, 73:6-16, doi:10.1136/annrheumdis-2013-203419

International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
Nancy Agmon-Levin, Jan Damoiseaux, Cees Kallenberg et al.
Ann Rheum Dis 2014, 73:17-23, doi:10.1136/annrheumdis-2013-203863

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
Francisca Sivera, Mariano Andrés, Loreto Carmona et al.
Ann Rheum Dis 2014, 73:328-335, doi:10.1136/annrheumdis-2013-203325

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S Smolen, Robert Landewé, Ferdinand C Breedveld et al.
Ann Rheum Dis 2014, 73:492-509, doi:10.1136/annrheumdis-2013-204573

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
Ronald F van Vollenhoven, Marta Mosca, George Bertsias et al.
Ann Rheum Dis 2014, 73:958-967, doi:10.1136/annrheumdis-2013-205139

Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice
Anne Grete Semb, Silvia Rollefstad, Piet van Riel et al.
Ann Rheum Dis 2014, 73:1284-1288, doi:10.1136/annrheumdis-2013-204792

Vaccines and biologics
Isabel Ferreira, David Isenberg
Ann Rheum Dis 2014, 73:1446-1454, doi:10.1136/annrheumdis-2014-205246

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
Paul Emery, Anthony Sebba, Tom W J Huizinga
Ann Rheum Dis 2013, 72:1897-1904, doi:10.1136/annrheumdis-2013-203485

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
N Duru, M C van der Goes, J W G Jacobs
Ann Rheum Dis 2013, 72:1905-1913, doi:10.1136/annrheumdis-2013-203249

2013 classification criteria for systemic sclerosis: an American College of Rheumatology / European League Against Rheumatism collaborative initiative
CFrank van den Hoogen, Dinesh Khanna, Jaap Fransen et al.
Ann Rheum Dis 2013, 72:1747-1755, doi:10.1136/annrheumdis-2013-204424 5

Drug therapy in undifferentiated arthritis: a systematic literature review
K V C Wevers-de Boer, L Heimans, T W J Huizinga et al.
Ann Rheum Dis 2013, 72:1436-1444, doi:10.1136/annrheumdis-2012-203165

Understanding hypercitrullination in rheumatoid arthritis
Katrina Ray
Nature Reviews Rheumatology 10, 3 (2014), doi:10.1038/nrrheum.2013.182

Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys
Aikaterini Thanou, Joan T. Merrill
Nature Reviews Rheumatology 10, 23-34 (2014), doi:10.1038/nrrheum.2013.145

Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Pier Luigi Meroni, Martina Biggioggero, Silvia S. Pierangeli et al.
Nature Reviews Rheumatology 10, 35-43 (2014), doi:10.1038/nrrheum.2013.180

Pragmatic approaches to therapy for systemic lupus erythematosus
Wen Xiong, Robert G. Lahita
Nature Reviews Rheumatology 10, 97-107 (2014), doi:10.1038/nrrheum.2013.157

Emerging cell and cytokine targets in rheumatoid arthritis
Gerd R. Burmester, Eugen Feist, Thomas Dörner
Nature Reviews Rheumatology 10, 77-88 (2014), doi:10.1038/nrrheum.2013.168

Risk estimation in rheumatoid arthritis-from bench to bedside
Annette H. M. van der Helm-van Mil
Nature Reviews Rheumatology 10, 171-180 (2014), doi:10.1038/nrrheum.2013.215

Hand osteoarthritis-nonpharmacological and pharmacological treatments
Margreet Kloppenburg
Nature Reviews Rheumatology 10, 242-251 (2014), doi:10.1038/nrrheum.2013.214

Optimizing current treatment of gout
Frances Rees, Michelle Hui, Michael Doherty
Nature Reviews Rheumatology 10, 271-283 (2014), doi:10.1038/nrrheum.2014.32

Genetic and epigenetic predictors of responsiveness to treatment in RA
Darren Plant, Anthony G. Wilson, Anne Barton
Nature Reviews Rheumatology 10, 329-337 (2014), doi:10.1038/nrrheum.2014.16

Diagnosis and management of neuropsychiatric SLE
John G. Hanly
Nature Reviews Rheumatology 10, 338-347 (2014), doi:10.1038/nrrheum.2014.15

Rheumatoid arthritis: Is imaging needed to define remission in rheumatoid arthritis?
Mikkel Østergaard, Signe Møller-Bisgaard
Nature Reviews Rheumatology 10, 326-328 (2014), doi:10.1038/nrrheum.2014.63

Selection bias in rheumatic disease research
Hyon K. Choi, Uyen-Sa Nguyen, Jingbo Niu et al.
Nature Reviews Rheumatology 10, 403-412 (2014), doi:10.1038/nrrheum.2014.36

Safety of Immunosuppressive Drugs in Pregnant Women With Systemic Inflammatory Diseases
Seoyoung C. Kim, Sonia Hernandez-Diaz
Arthritis & Rheumatology, 66, 2, 246-249, 2014, DOI: 10.1002/art.38258

Antinucleosome Antibodies: A Critical Reflection on Their Specificities and Diagnostic Impact
Ole Petter Rekvig, Johan van der Vlag, Natalya Seredkina
Arthritis & Rheumatology, 66, 5, 1061-1069, 2014, DOI: 10.1002/art.38365